Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Current Radiopharmaceuticals is Scopus-indexed (Q2, CiteScore 3.2), WoS SCIE. Published by KeAi Communications Co..
Checked against the index lists dated .
ISSN 1874-4710Verify ISSN ↗1874-4729Verify ISSN ↗
Publisher: KeAi Communications Co.
Cost to publish: No APC data — check the publisher
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Radiology, Nuclear Medicine and Imaging | 170 / 361 | 52nd | Q2 |
| Pharmacology | 206 / 328 | 37th | Q3 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2009–present, best quartile Q2, CiteScore 3.2.
Current Radiopharmaceuticals is Q2 in Radiology, Nuclear Medicine and Imaging (rank 170 of 361) and Q3 in Pharmacology (rank 206 of 328), by CiteScore 2025.
Current Radiopharmaceuticals is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 3.2, which places it in quartile Q2 at the 52nd percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.394, quartile Q3, with an H-index of 37.
Current Radiopharmaceuticals is published by KeAi Communications Co. Its print ISSN is 1874-4710 and its online ISSN is 1874-4729.
Yes — indexed in the Science Citation Index Expanded.
No — it is not registered as an open-access journal in DOAJ or Scopus.
Current Radiopharmaceuticals has an h-index of 43 and a 2-year mean of 1.81 citations per paper (OpenAlex). Its Scopus CiteScore is 3.2, quartile Q2. On 2-year citations it ranks #137 of 346 Scopus journals in Radiology, Nuclear Medicine and Imaging.
Current Radiopharmaceuticals published 29 papers in 2025; its busiest recent year was 2020 with 50. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 95 research articles (2024–2026), authors are most often from China (37.4%), India (18.2%) and Iran (13%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.